Pathological jaundice in full-term newborns and Gilbert’s syndrome
Abstract
Background: In the course of our research on polymorphism in the UGT1A1 gene of healthy full-term newborns, we studied the relationship between pathological jaundice and the newborn’s genotype. The latter could be one of the risk factors for hyperbilirubinemia. The possibility of a pharmacogenetic approach for treating individuals with Gilbert’s syndrome was investigated since the polymorphism may influence the toxic metabolism of certain therapeutic drugs. Methods: Blood was collected from 185 healthy full-term newborns, born in May 2009, on the third day of life. Bilirubin was measured according to the Jendrassik-Grof method and all samples were genotyped (dHPLC method). ANOVA, χ2–test and t – test were used for statistical analysis. Results: A significant association of genotype with bilirubin levels was observed (p< 0.001), the highest bilirubin level occurring with the genotype (TA)7/7, characteristic of Gilbert ‘s syndrome; 68 of the 185 newborns had pathological jaundice; 20 cases were so severe that they needed phototherapy during hospitalization. Differences in bilirubin levels between the groups with clinical characteristics of jaundice were statistically significant (physiological / pathological (p< 0.001) and irradiated / nonirradiated (p = 0,034)). The genotype (TA)7/7 was significantly more frequent in the group with pathological jaundice than in the group with physiological jaundice (p = 0,028). The results confirm that Gilbert’s syndrome can be one of the factors contributing to pathological jaundice in healthy full-term newborns. polymorphism in the UGT1A1 gene of healthy full-term newborns, we studied the relationship between pathological jaundice and the newborn’s genotype. The latter could be one of the risk factors for hyperbilirubinemia. The possibility of a pharmacogenetic approach for treating individuals with Gilbert’s syndrome was investigated since the polymorphism may influence the toxic metabolism of certain therapeutic drugs. Conclusions: The results suggest that, besides the screening test for determining cord blood bilirubin, genetic screening should be carried out in newborns with pathological jaundice to identify individuals with Gilbert’s syndrome.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.